A State-of-the-Art Research & Development Environment
At Boehringer Ingelheim, research & development is conducted at four major research & development sites and three support centres in Europe, the Americas and Asia. Clinical research takes place in nearly 50 countries. Key to success in research & development are good people with the best scientific and technological knowledge, flexible thinking and good communication, who work well with their peers inside and outside the company.
Centres & Technologies
-
R&D CentresBoehringer Ingelheim's worldwide research, development and support centres. read more
-
Research Institute IMPThe bridge between industry and academia is strengthened by the Research Institute of Molecular Pathology (IMP) in Vienna (Austria). read more
-
TechnologiesBoehringer Ingelheim's successful drug discovery relies on excellent interdisciplinary cooperation and well-functioning medicinal chemistry with state-of-the-art tools. read more
